Long term followup of photorefractive keratectomy with adjuvant use of mitomycin C

Citations of this article
Mendeley users who have this article in their library.


Purpose. To study the long term refractive and visual outcomes of photorefractive keratectomy (PRK) with intraoperative application of mitomycin C (MMC). Methods. This study included 37 eyes who received myopic PRK; after photoablation, a sponge soaked in 0.02% MMC solution was applied in all corneas for 2 minutes. Efficacy, safety, predictability, and stability of PRK MMC were evaluated. Endothelial cell density was evaluated at the last postoperative interval. Results. Mean preoperative spherical equivalent (SEQ) was -6.03±1.87 D (diopters) and reduced to -0.09±0.53 D at the last postoperative examination. Mean followup was 44.73±18.24 months. All the eyes were in the ±1.00 D of attempted versus achieved SEQ at the one-year follow-up interval. Furthermore, 95% of the eyes did not lose lines or gained 1 to 2 lines of CDVA, while 5% lost 1 line. At the third postoperative month, 89% of the eyes either were clear or had trace haze, while 4 eyes had mild haze; by the 12-month postoperative interval, none of the eyes demonstrated haze. Mean endothelial cell density (ECD) at the last postoperative interval was 2658±153 cells/mm2. Conclusions. PRK, with intraoperative use of MMC, demonstrates stable refractive and visual outcomes up to 44 months after surgery. © 2014 Vasilios F. Diakonis et al.




Diakonis, V. F., Kankariya, V. P., Kymionis, G. D., Kounis, G., Kontadakis, G., Gkenos, E., … Pallikaris, I. G. (2014). Long term followup of photorefractive keratectomy with adjuvant use of mitomycin C. Journal of Ophthalmology, 2014. https://doi.org/10.1155/2014/821920

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free